Treatments for Relapsed and Refractory Multiple Myeloma

Video

Treatments for Relapsed and Refractory Multiple Myeloma

CASE: A 72-year-old Caucasian Man With Relapsed Multiple Myeloma

September 2016

  • Patient history: At the age of 72, a Caucasian man was diagnosed with multiple myeloma; R-ISS stage I
  • Other relevant history includes hypertension and difficulty walking up stairs
  • He was treated with lenalidomide/dexamethasone and achieved a VGPR
  • Treatment duration was 9 months; patient subsequently discontinued therapy 12 months ago

June 2018

  • On routine follow-up, patient complains of increasing problems with fatigue, and has rising levels of M protein
  • Laboratory results:
    • Hb, 9.6 g/dL
    • Ca2+9.2 mg/dL
    • Creatinine, 0.8 mg/dL
    • M-protein, 3.0 g/dL
    • 30% plasma cells in bone marrow
  • Cytogenetics/FISH: del(17p)
  • ECOG PS: 2
Related Videos
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Related Content